An amyloid protein build-up in the brain is the early onset of Alzheimer’s disease. In order to fight off the amyloid fibrils, a molecule would have to cross the blood-brain barrier, so the researchers wanted to find out which compounds would be able to do so.
The team separated and identified 21 compounds from pomegranate extract and found that although previous research found that polyphenols could not cross the blood-brain barrier, urolithins could. Urolithins are anti-inflammatory and neuroprotective compounds that are formed in the gut. The researchers found that urolithins were able to reduce Aß fibrillation levels in vitro. These compounds also increased the lifespan of Alzheimer’s roundworm models.
Additional testing is required to determine the effects of pomegranate extract on humans.
The findings were published in ACS Chemical Neuroscience.